ACTINIUM PHARMACEUTICALS INC's ticker is ATNM and the CUSIP is 00507W206. A total of 55 filers reported holding ACTINIUM PHARMACEUTICALS INC in Q3 2022. The put-call ratio across all filers is 0.22 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $118 | -99.8% | 20 | -99.7% | 0.00% | – |
Q2 2023 | $57,475 | -87.8% | 7,746 | -84.4% | 0.00% | – |
Q1 2023 | $470,714 | -10.1% | 49,811 | +1.3% | 0.00% | – |
Q4 2022 | $523,469 | +834.8% | 49,152 | +544.3% | 0.00% | – |
Q3 2022 | $56,000 | +460.0% | 7,629 | +659.1% | 0.00% | – |
Q3 2020 | $10,000 | – | 1,005 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sentinus, LLC | 149,050 | $1,408,523 | 0.47% |
Intrepid Financial Planning Group LLC | 19,000 | $179,550 | 0.09% |
PERRITT CAPITAL MANAGEMENT INC | 12,000 | $113,400 | 0.06% |
Interchange Capital Partners, LLC | 11,413 | $107,853 | 0.06% |
Virtu Financial LLC | 21,650 | $205 | 0.02% |
CREATIVE FINANCIAL DESIGNS INC /ADV | 15,000 | $141,750 | 0.02% |
J. Goldman & Co LP | 42,228 | $399,055 | 0.02% |
BRIDGEWAY CAPITAL MANAGEMENT, LLC | 63,966 | $604,479 | 0.02% |
KENNEDY CAPITAL MANAGEMENT LLC | 46,311 | $437,639 | 0.01% |
683 Capital Management, LLC | 16,000 | $151,200 | 0.01% |